Other disease associations with non-alcoholic fatty liver disease (NAFLD)

被引:39
|
作者
Allard, JP [1 ]
机构
[1] Univ Toronto, Toronto Gen Hosp, Toronto, ON M5G 2C4, Canada
关键词
non-alcoholic steatohepatitis; jejunoileal bypass; obesity; parenteral nutrition; drugs; malnutrition;
D O I
10.1053/bega.2002.0330
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is usually seen in middle-aged women with obesity, non-insulin-dependent diabetes mellitus and/or hyperlipidaemia. NAFLD has also been associated with other conditions. Surgical procedures to treat obesity such as jejunoileal bypass and gastroplasty as well as massive small bowel resection have been associated with NAFLD. Mechanisms such as rapid weight loss, certain nutritional deficiencies and bacterial overgrowth have been proposed. Other nutritional conditions such as extreme malnutrition and total parenteral nutrition can also cause NASH. This can be due to abnormal glucose and fat metabolism, deficiencies like carnitine, essential fatty acid and choline or, in the case of parenteral nutrition, excess of calories, glucose or lipids. Several drugs have also been implicated as well as some inborn errors of metabolism and, more rarely, other diseases.
引用
收藏
页码:783 / 795
页数:13
相关论文
共 50 条
  • [41] Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Saeed, Ali
    Dullaart, Robin P. F.
    Schreuder, Tim C. M. A.
    Blokzijl, Hans
    Faber, Klaas Nico
    NUTRIENTS, 2018, 10 (01)
  • [42] Metabolic syndrome (MS) in non-alcoholic fatty liver disease (NAFLD)
    Bugianesi, E
    Marchesini, G
    Manini, R
    Moscatiello, S
    Striuli, L
    Vanni, E
    Gentilcore, E
    Zanotti, E
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 191 - 191
  • [43] Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts
    Papatheodoridi, Margarita
    Cholongitas, Evangelos
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (38) : 4574 - 4586
  • [44] Protective Role of Coffee in Non-alcoholic Fatty Liver Disease (NAFLD)
    Catalano, Daniela
    Martines, Giuseppe Fabio
    Tonzuso, Antonia
    Pirri, Clara
    Trovato, Francesca M.
    Trovato, Guglielmo M.
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (11) : 3200 - 3206
  • [45] Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)
    Yoneda, M.
    Fujita, K.
    Inamori, M.
    Nakajima, A.
    Yoneda, M.
    Tamano, M.
    Hiraishi, H.
    GUT, 2007, 56 (09) : 1330 - 1331
  • [46] Redox Homeostasis and Epigenetics in Non-alcoholic Fatty Liver Disease (NAFLD)
    Podrini, Christine
    Borghesan, Michela
    Greco, Azzura
    Pazienza, Valerio
    Mazzoccoli, Gianluigi
    Vinciguerra, Manlio
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (15) : 2737 - 2746
  • [47] TESTOSTERONE REDUCES NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) OF HYPOGONADISM
    Nikolaenko, L.
    Diaz-Arjonilla, M.
    Laurel, S.
    Wang, C.
    Lue, Y.
    French, S.
    Swerdloff, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (01) : 120 - 120
  • [48] Two cases of non-alcoholic fatty liver disease (NAFLD) in childhood
    Takubo, Noriyuki
    Kitsuda, Kazuteru
    Outsu, Shigeyuki
    Kazahari, Mayumi
    Yokota, Yukifumi
    Matsuura, Nobuo
    Ishii, Masahiro
    HORMONE RESEARCH, 2009, 72 : 499 - 499
  • [49] Protective Role of Coffee in Non-alcoholic Fatty Liver Disease (NAFLD)
    Daniela Catalano
    Giuseppe Fabio Martines
    Antonia Tonzuso
    Clara Pirri
    Francesca M. Trovato
    Guglielmo M. Trovato
    Digestive Diseases and Sciences, 2010, 55 : 3200 - 3206
  • [50] Non-alcoholic Fatty Liver Disease (NAFLD) causes Erythropoietin Hyporesponsiveness
    Zou, Huixi
    Yan, Xiaoyu
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385